Pfizer Plans 12% Cost Cut as Sales Lag
Pfizer and other pharmaceutical companies are greedy and deserve to go broke. Note the following from the story:
By 2007, Pfizer will face low-priced generic competition for a half-dozen drugs that now account for almost 30 percent of its sales and billions of dollars in profits.
The New York Times > Business > Pfizer Plans 12% Cost Cut as Sales Lag
By 2007, Pfizer will face low-priced generic competition for a half-dozen drugs that now account for almost 30 percent of its sales and billions of dollars in profits.
The New York Times > Business > Pfizer Plans 12% Cost Cut as Sales Lag
posted by Norman Larson @ 7:14 AM
0 Comments:
Post a Comment
<< Home